Ende Eric J has filed 17 insider transactions across 2 companies since May 2023.
Most recent transaction: a disposition of 11000 shares of AVADEL PHARMACEUTICALS PLC ($AVDL) on February 12, 2026.
Activity breakdown: 2 open-market purchases and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 12, 2026 | AVADEL PHARMACEUTICALS PLC | $AVDL | Ende Eric J | Director | D | Stock Option (Right to Buy) | 11000 | $0.00 | 0.0000 | 101,276,000 | 100.00% | 0.01% |
| Feb. 12, 2026 | AVADEL PHARMACEUTICALS PLC | $AVDL | Ende Eric J | Director | D | Ordinary Shares | 219905 | $21.00 | 0.0000 | 101,276,000 | 100.00% | 0.22% |
| Feb. 12, 2026 | AVADEL PHARMACEUTICALS PLC | $AVDL | Ende Eric J | Director | D | Stock Option (Right to Buy) | 8057 | $0.00 | 0.0000 | 101,276,000 | 100.00% | 0.01% |
| Feb. 12, 2026 | AVADEL PHARMACEUTICALS PLC | $AVDL | Ende Eric J | Director | D | Stock Option (Right to Buy) | 60000 | $0.00 | 0.0000 | 101,276,000 | 100.00% | 0.06% |
| Feb. 12, 2026 | AVADEL PHARMACEUTICALS PLC | $AVDL | Ende Eric J | Director | D | Stock Option (Right to Buy) | 42000 | $0.00 | 0.0000 | 101,276,000 | 100.00% | 0.04% |
| Feb. 12, 2026 | AVADEL PHARMACEUTICALS PLC | $AVDL | Ende Eric J | Director | D | Stock Option (Right to Buy) | 42000 | $0.00 | 0.0000 | 101,276,000 | 100.00% | 0.04% |
| Feb. 12, 2026 | AVADEL PHARMACEUTICALS PLC | $AVDL | Ende Eric J | Director | D | Stock Option (Right to Buy) | 42000 | $0.00 | 0.0000 | 101,276,000 | 100.00% | 0.04% |
| Feb. 12, 2026 | AVADEL PHARMACEUTICALS PLC | $AVDL | Ende Eric J | Director | D | Stock Option (Right to Buy) | 33000 | $0.00 | 0.0000 | 101,276,000 | 100.00% | 0.03% |
| Feb. 12, 2026 | AVADEL PHARMACEUTICALS PLC | $AVDL | Ende Eric J | Director | D | Stock Option (Right to Buy) | 11000 | $0.00 | 0.0000 | 101,276,000 | 100.00% | 0.01% |
| July 29, 2025 | AVADEL PHARMACEUTICALS PLC | $AVDL | Ende Eric J | Director | A | Stock Option (Right to Buy) | 11000 | $0.00 | 11,000.0000 | 95,141,000 | 9999.99% | 0.01% |
| July 29, 2025 | AVADEL PHARMACEUTICALS PLC | $AVDL | Ende Eric J | Director | A | Ordinary Shares | 11000 | $0.00 | 219,900.0000 | 95,141,000 | 5.27% | 0.01% |
| Jan. 13, 2025 | AVADEL PHARMACEUTICALS PLC | $AVDL | Ende Eric J | Director | P | Ordinary Shares | 30000 | $7.84 | 208,900.0000 | 95,141,000 | 16.77% | 0.03% |
| July 30, 2024 | AVADEL PHARMACEUTICALS PLC | $AVDL | Ende Eric J | Director | A | Ordinary Shares | 11000 | $0.00 | 178,900.0000 | 80,174,000 | 6.55% | 0.01% |
| July 30, 2024 | AVADEL PHARMACEUTICALS PLC | $AVDL | Ende Eric J | Director | A | Stock Option (Right to Buy) | 11000 | $0.00 | 11,000.0000 | 80,174,000 | 9999.99% | 0.01% |
| Nov. 1, 2023 | Matinas BioPharma Holdings, Inc. | $MTNB | Ende Eric J | Director | A | Stock option (right to buy) | 437244 | $0.00 | 437,244.0000 | 0 | 9999.99% | 0.00% |
| Aug. 1, 2023 | AVADEL PHARMACEUTICALS PLC | $AVDL | Ende Eric J | Director | A | Stock Option (Right to Buy) | 33000 | $0.00 | 33,000.0000 | 60,094,000 | 9999.99% | 0.05% |
| May 18, 2023 | AVADEL PHARMACEUTICALS PLC | $AVDL | Ende Eric J | Director | P | ADSs | 13000 | $13.93 | 167,900.0000 | 60,094,000 | 8.39% | 0.02% |